投标竞争、企业群体性败德与集中采购绩效

发布时间：2018-02-25 23:14

  本文关键词： 药品集中采购 群体性败德 双信封制 价格下限 质量分层　出处：《经济管理》2017年05期 　论文类型：期刊论文

【摘要】：本文从企业群体性败德这一视角出发,探讨药品集中采购绩效低下的原因以及可行的改进措施。研究表明,片面追求低价格的原有招标模式本身存在的缺陷以及相应出现的正向激励不足,是药品集中采购制度失效的根本原因。相比之下,价格与质量并重的双信封制是更加合理、有效的集中采购模式。当然,在推广双信封制时,必须同时完善与实施质量审核、资质评定、信息公开、监管执法、创新补贴等配套制度与措施。特别地,设置价格下限、质量分层招标等举措有助于抑制企业可能采取的败德行为、增强其在规范生产经营与增加创新投入方面的激励,从而切实提高药品集中采购绩效、保证其作用得到充分发挥。
[Abstract]:This paper discusses the reasons for the low performance of centralized drug procurement and the feasible improvement measures from the point of view of corporate group failure. The defects of the original bidding mode of one-sided pursuit of low price and the corresponding lack of positive incentives are the fundamental reasons for the failure of the centralized drug purchasing system. In contrast, the two-envelope system with equal emphasis on price and quality is more reasonable. Effective centralized purchasing mode. Of course, in promoting the double envelopes system, we must simultaneously improve and implement the supporting systems and measures such as quality audit, qualification evaluation, information disclosure, supervision and enforcement, innovation subsidies, etc. In particular, set the lower price limit. The measures such as quality stratified bidding will help to restrain the possible demoralization behavior of enterprises, strengthen their incentives in standardizing production and management and increasing innovation input, so as to effectively improve the performance of centralized drug procurement and ensure that its role is brought into full play.
【作者单位】： 中国人民大学经济学院;
【基金】：中国人民大学2015年度拔尖创新人才培育资助计划 国家社会科学基金项目“食品防护情境下内部举报行为之激励机制研究”(15BJL032)
【分类号】：R95
，

本文编号：1535555